Search research articles
Contact Us
Filters
Showing results (191-200 of 246) with videos related to
Page
of 25
Sort By:
Diabetologia
|
December 3, 2003
Superior renoprotective effects of combination therapy with ACE and AGE inhibition in the diabetic spontaneously hypertensive rat
B J Davis, J M Forbes, M C Thomas, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
August 26, 1998
Vascular endothelial growth factor and its receptors in control and diabetic rat eyes
R E Gilbert, D Vranes, J L Berka, et al.
Diabetologia
|
July 3, 2008
The HMG-CoA reductase inhibitor rosuvastatin and the angiotensin receptor antagonist candesartan attenuate atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes via effects on advanced glycation, oxidative stress and inflammation
A C Calkin, S Giunti, K J Sheehy, et al.
Clinical Genetics
|
August 25, 2004
TP63 mutation and clefting modifier genes in an EEC syndrome family
A K Ray, M L Marazita, R Pathak, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
December 21, 2010
Large artery biomechanics and diastolic dysfunctionin patients with Type 2 diabetes
G Soldatos, K Jandeleit-Dahm, H Thomson, et al.
Kidney International
|
March 22, 2001
PDGF signal transduction inhibition ameliorates experimental mesangial proliferative glomerulonephritis
R E Gilbert, D J Kelly, T McKay, et al.
Journal of the American College of Cardiology
|
September 1, 1996
Contemporary practice of coronary revascularization in U.S. hospitals and hospitals participating in the bypass angioplasty revascularization investigation (BARI)
K M Detre, A D Rosen, J E Bost, et al.
Journal of Dental Research
|
September 23, 2010
Taste genes associated with dental caries
S Wendell, X Wang, M Brown, et al.
Circulation Research
|
February 10, 2000
Endothelin receptor antagonism ameliorates mast cell infiltration, vascular hypertrophy, and epidermal growth factor expression in experimental diabetes
R E Gilbert, J R Rumble, Z Cao, et al.
Diabetologia
|
October 1, 2010
Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial
Y Miao, D Dobre, H J Lambers Heerspink, et al.
Page
of 25
Search research articles
Search
Showing results (191-200 of 246) with videos related to
Sort By:
Page
of 25
Diabetologia
|
December 3, 2003
Superior renoprotective effects of combination therapy with ACE and AGE inhibition in the diabetic spontaneously hypertensive rat
B J Davis, J M Forbes, M C Thomas, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
August 26, 1998
Vascular endothelial growth factor and its receptors in control and diabetic rat eyes
R E Gilbert, D Vranes, J L Berka, et al.
Diabetologia
|
July 3, 2008
The HMG-CoA reductase inhibitor rosuvastatin and the angiotensin receptor antagonist candesartan attenuate atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes via effects on advanced glycation, oxidative stress and inflammation
A C Calkin, S Giunti, K J Sheehy, et al.
Clinical Genetics
|
August 25, 2004
TP63 mutation and clefting modifier genes in an EEC syndrome family
A K Ray, M L Marazita, R Pathak, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
December 21, 2010
Large artery biomechanics and diastolic dysfunctionin patients with Type 2 diabetes
G Soldatos, K Jandeleit-Dahm, H Thomson, et al.
Kidney International
|
March 22, 2001
PDGF signal transduction inhibition ameliorates experimental mesangial proliferative glomerulonephritis
R E Gilbert, D J Kelly, T McKay, et al.
Journal of the American College of Cardiology
|
September 1, 1996
Contemporary practice of coronary revascularization in U.S. hospitals and hospitals participating in the bypass angioplasty revascularization investigation (BARI)
K M Detre, A D Rosen, J E Bost, et al.
Journal of Dental Research
|
September 23, 2010
Taste genes associated with dental caries
S Wendell, X Wang, M Brown, et al.
Circulation Research
|
February 10, 2000
Endothelin receptor antagonism ameliorates mast cell infiltration, vascular hypertrophy, and epidermal growth factor expression in experimental diabetes
R E Gilbert, J R Rumble, Z Cao, et al.
Diabetologia
|
October 1, 2010
Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial
Y Miao, D Dobre, H J Lambers Heerspink, et al.
Page
of 25